New Study Findings Show No Benefit Of Prescription Omega-3 Fatty Acids In Prevention Of Recurrent Symptomatic Atrial Fibrillation In Affected Patients

Findings from a new study show, compared to placebo, treatment with high-dose prescription omega-3 fatty acids did not reduce the recurrence of symptomatic atrial fibrillation (AF) among patients with symptomatic paroxysmal AF or persistent AF who have no evidence of substantial structural heart disease…